ROCHE has announced it has signed a definitive agreement to acquire Flatiron Health, a maker of oncology-focused electronic health records.
The Swiss multinational healthcare company, with a strong focus on oncology products, already has almost 13% stake in the New York City-based firm and has said it will pay $1.9 billion to Flatiron Health to close the deal in the first half of this year.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 18
